Acute care and monitoring
Corsano™* multi-parameter wearable
Continuous. Connected. Clinically proven.
The Corsano™* multi-parameter wearable is a medical-grade wrist device that continuously captures key vital parameters, with real-time tracking to inform decision making. 1-3
Designed for patient comfort, it connects seamlessly to hospital systems and extends visibility of patient vital signs from both the hospital and home settings.1
*Third-party brands are trademarks of their respective owners.
Tetherless for freedom of movement
Weight 19 grams
Battery life up to 7 days
Water resistant†
Continuous measurement of vital signs, including SpO2, heart rate, and skin temperature
Algorithms and vital sign trending
FDA cleared
†Do not submerge. Protected against dust and powerful water jets only.
Collecting vitals manually every 4–6 hours can leave patients unmonitored 96% of the time, potentially missing early signs of deterioration.5
The Corsano™* multi-parameter wearable delivers continuous, real-time patient monitoring — so care doesn’t stop between spot checks.
‡Based on studies done on wearable devices using the same, or some of the same, monitoring parameters as the Corsano™* multi-parameter wearable.
Testimonial from Manchester University Hospital
Testimonial from West Middlesex Hospital
†Claims based on studies done on wearable devices using the same, or some of the same, monitoring parameters as the Corsano™* multi-parameter wearable.
The Corsano™* multi-parameter wearable is manufactured by Corsano Health B.V and distributed by Medtronic.
The Corsano™* multi-parameter wearable should not be used as the sole basis for diagnosis or therapy and is intended only as an adjunct in patient assessment.
*Third-party brands are trademarks of their respective owners
1. Corsano CardioWatch 287-2, Bracelet & Mobile Patient App Instruction Manual.
2. Stellpflug C, Pierson L, Roloff D, et al. Continuous Physiological Monitoring Improves Patient Outcomes. AJN The American Journal of Nursing. 2021 ;121(4):40. doi:10.1097 /01.NAJ.0000742504.44428.c9.
3. U.S. Food and Drug Administration, Center for Devices and Radiological Health. (2024, March 22). 510(k) summary: Corsano CardioWatch 287-2 System (K232548) [510(k) summary]. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm (REF-34983)
4. Report 20240620: Corsano CardioWatch_Clinical Evaluation Summary Report 20240620 (REF-29058)
5. Curry JP, Jungquist CR. A critical assessment of monitoring practices, patient deterioration, and alarm fatigue on inpatient wards: a review. Patient Saf Surg. 2014 Jun 27;8:29. doi: 10.1186/1754-9493-8-29. PMID: 25093041; PMCID: PMC4109792. (REF-00382)
6. Weller GB, Mault J, Ventura ME, Adams J, Campbell FJ, Tremper KK. A Retrospective Observational Study of Continuous Wireless Vital Sign Monitoring via a Medical Grade Wearable Device on Hospitalized Floor Patients. J Clin Med. 2024;13(16):4747. doi: 10.3390/jcm13164747. PMID: 39200889; PMCID: PMC11355593. (REF-26018)
7. Narcisse V, lshaq F, Gomez M, et al. Implementation of Remote Patient Monitoring and Earlier CERT Activation: Effects on ICU Transfer and Mortality. Journal of Clinical Medicine. 2025;14:7434. doi:10.3390/jcm14207434.